Albert Yick Hou Lim1,2,3, Jun Leng Goh4, Mae Chui Wei Chua4, Bee Hoon Heng5, John Arputham Abisheganaden6,4,7, Pradeep Paul George7,5,8. 1. Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, National Healthcare Group, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore. albert_ly_hou@ttsh.com.sg. 2. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. albert_ly_hou@ttsh.com.sg. 3. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. albert_ly_hou@ttsh.com.sg. 4. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 5. Health Services and Outcomes Research, National Healthcare Group, Singapore, Singapore. 6. Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, National Healthcare Group, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore. 7. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. 8. Faculty of Health Sciences, University of Adelaide, Adelaide, Australia.
Abstract
BACKGROUND: COVID-19 is a systemic viral infection which mainly targets the human respiratory system with many secondary clinical manifestations especially affecting the hematopoietic system and haemostasis. Few studies have highlighted the prognostic value of blood findings such as lymphopenia, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, LDH, CRP, cardiac troponin, low-density lipoproteins and chest radiographic abnormality. A study of progressions of blood and radiological results may help to identify patients at high risk of severe outcomes. This systematic review aimed to assess the temporal progression of blood and radiology findings of patients with COVID-19. METHODS: Comprehensive systematic literature search was conducted on Medline, Embase and Cochrane databases to identify articles published for peripheral blood investigation and radiological results of COVID-19 patients. RESULTS: A total of 27 studies were included in this review. The common laboratory features reported include lymphopenia, elevated levels of C-reactive proteins and lactate dehydrogenase. For radiological signs, ground-glass opacifications, consolidations, and crazy paving patterns were frequently reported. There is a correlation between lymphocyte count, neutrophil count and biomarkers such as C-reactive proteins and lactate dehydrogenase; at a later phase of the disease (more than 7 days since onset of symptoms), lymphopenia worsens while neutrophil count, C-reactive protein levels and lactate dehydrogenase levels increase. Frequencies of ground-glass opacifications and ground-glass opacifications with consolidations decrease at a later phase of the disease while that of consolidation and crazy paving pattern rises as the disease progresses. More extensive lung involvement was also seen more frequently in the later phases. CONCLUSION: The correlation between temporal progression and the reported blood and radiological results may be helpful to monitor and evaluate disease progression and severity.
BACKGROUND:COVID-19 is a systemic viral infection which mainly targets the humanrespiratory system with many secondary clinical manifestations especially affecting the hematopoietic system and haemostasis. Few studies have highlighted the prognostic value of blood findings such as lymphopenia, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, LDH, CRP, cardiac troponin, low-density lipoproteins and chest radiographic abnormality. A study of progressions of blood and radiological results may help to identify patients at high risk of severe outcomes. This systematic review aimed to assess the temporal progression of blood and radiology findings of patients with COVID-19. METHODS: Comprehensive systematic literature search was conducted on Medline, Embase and Cochrane databases to identify articles published for peripheral blood investigation and radiological results of COVID-19patients. RESULTS: A total of 27 studies were included in this review. The common laboratory features reported include lymphopenia, elevated levels of C-reactive proteins and lactate dehydrogenase. For radiological signs, ground-glass opacifications, consolidations, and crazy paving patterns were frequently reported. There is a correlation between lymphocyte count, neutrophil count and biomarkers such as C-reactive proteins and lactate dehydrogenase; at a later phase of the disease (more than 7 days since onset of symptoms), lymphopenia worsens while neutrophil count, C-reactive protein levels and lactate dehydrogenase levels increase. Frequencies of ground-glass opacifications and ground-glass opacifications with consolidations decrease at a later phase of the disease while that of consolidation and crazy paving pattern rises as the disease progresses. More extensive lung involvement was also seen more frequently in the later phases. CONCLUSION: The correlation between temporal progression and the reported blood and radiological results may be helpful to monitor and evaluate disease progression and severity.
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: J Clin Epidemiol Date: 2009-07-23 Impact factor: 6.437
Authors: Stephen A Lauer; Kyra H Grantz; Qifang Bi; Forrest K Jones; Qulu Zheng; Hannah R Meredith; Andrew S Azman; Nicholas G Reich; Justin Lessler Journal: Ann Intern Med Date: 2020-03-10 Impact factor: 25.391
Authors: David S Hui; Esam I Azhar; Tariq A Madani; Francine Ntoumi; Richard Kock; Osman Dar; Giuseppe Ippolito; Timothy D Mchugh; Ziad A Memish; Christian Drosten; Alimuddin Zumla; Eskild Petersen Journal: Int J Infect Dis Date: 2020-01-14 Impact factor: 3.623
Authors: Samuele Ceruti; Bruno Minotti; Andrea Glotta; Maira Biggiogero; Giovanni Bona; Martino Marzano; Pietro Greco; Marco Spagnoletti; Christian Garzoni; Karim Bendjelid Journal: J Clin Med Date: 2022-01-31 Impact factor: 4.241